Form 990 for tax year 2024
Filed by PEDIATRIC CANCER RESEARCH FOUNDATION.
This return was superseded by a later amendment. matched by us It is kept because history is preserved rather than replaced.
What the amendment changed
Compared with the latest return for 2024 , filed 18 March 2026. matched by us Only the Part I totals and the names listed in Part VII are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.
- Total revenue
- $1,384,349 changed to $4,224,824
- Total expenses
- $1,912,526 changed to $3,730,243
- Contributions and grants received
- $1,686,095 changed to $4,883,196
- Grants paid
- $914,813 changed to $1,695,918
- Program services expenses
- $1,193,411 changed to $2,261,147
- Management and general expenses
- $80,416 changed to $229,524
- Fundraising expenses
- $638,699 changed to $1,239,572
- Program service expenses (Part III)
- $1,193,411 changed to $2,261,147
Listed only on the earlier return
- JERI WILSON
- THOMAS BRENNAN
Listed only on the later return
- BONNIE LATTIMORE
- JERI WILLSON
- LEN SHULMAN
- MORGAN MARCH
- SAVANNAH SCHMIER
Listed under a different title
- DANIELLE FRAGALLA: CEO (AS OF 03/2024) then CEO
Totals
- Total revenue
- $1,384,349
- Total expenses
- $1,912,526
- Contributions and grants received
- $1,686,095
- Grants paid
- $914,813
- Program services expenses (Part IX)
- $1,193,411
- Management and general expenses
- $80,416
- Fundraising expenses
- $638,699
- Program service expenses (Part III)
- $1,193,411
Program services were 62.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Listed in Part VII
-
STEVE GIUSTO
PRESIDENT
- Total calculated
- $0
- Hours/week
- 1
-
JOHN COON
VICE PRESIDENT
- Total calculated
- $0
- Hours/week
- 1
-
THOMAS BRENNAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
BETH ABRAMS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
SUSIE BUCHAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
TIM CROMWELL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
CHERIE DALY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
SCOTT ECKER
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
KEITH KOELLER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
ELIZABETH MCNULTY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JASON O'DONNELL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
AMANDA SARATSIS MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JOHN VALLELY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
DARTH VAUGHN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JOHN WEINER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
NICOLE WILKINS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JERI WILSON
EXECUTIVE DIRECTOR
- Total calculated
- $0
- Hours/week
- 40
-
DANIELLE FRAGALLA
CEO (AS OF 03/2024)
- Total calculated
- $0
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$275,000
PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE
-
$75,000
TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS
-
$50,000
TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA
-
$50,000
TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML
-
$50,000
SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
-
$50,000
PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA
-
$49,563
REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE
-
$40,000
TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA
-
PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS
-
$37,500
USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
PEDIATRIC CANCER RESEARCH FOUNDATION NEW YORK A NOT FOR PROFIT CORPORATION
501(C)(3) · FUNDING SOURCE FOR RESEARCH · NY
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 2 April 2025
- IRS schema version
- 2024v5.1
- Source object
- 202521079349301112
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.